Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Advanced Solid Neoplasms × TAK-659 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Non-Hodgkin 3 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma 2 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Ovarian Neoplasms 1 Lymphoma, Follicular 1 Carcinoma, Non-Small-Cell Lung 1 Advanced Solid Tumor and Lymphoma Malignancies 1 Advanced Solid Neoplasms 1

Interventions

mitazalimab 1 TAK-659 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03338881 2023-02-08

A Study to Assess Mass Balance, Pharmacokinetics (PK), and Metabolism of Orally Administered [14 C]-TAK-659 in Participants With Advanced Solid Tumor and/or Lymphoma Malignancies

Calithera Biosciences, Inc

Phase 1 Withdrawn

Advanced Solid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡